NLRP3 and Huntington disease: Our findings were consistent with those of several previous studies that showed more severe oxidative damage in the brains of HD mice [38, 39]; daily treatment with the NLRP3 inhibitor MCC950 for 5 weeks from the age of 7 weeks markedly enhanced the level of glutathione in the striatum of R6/2 mice (Fig. 4H).